Skip to main content

Neonatal Encephalopathy clinical trials at UCSF
1 in progress, 1 open to new patients

  • High-dose Erythropoietin for Asphyxia and Encephalopathy

    open to all eligible people

    Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen to the brain near the time of birth. This results in death or neurologic disabilities including cerebral palsy and cognitive impairment in up to half of affected infants. This clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual therapy) will improve outcomes for infants suffering from HIE.

    San Francisco, California and other locations